UNSPSC 85408503: Diagnosis of balanced autosomal rearrangement in abnormal individual

This classification denotes the group of activities that yields a diagnosis of Balanced autosomal rearrangement in abnormal individual. Balanced autosomal rearrangement in abnormal individual is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as a four digit category under code Q95. 2

UNSPSC 85408503 Diagnosis of balanced autosomal rearrangement in abnormal individual is a Commodity code that shows minimal alignment with recent state and local procurement activity. The three opportunities posted in the source—a diagnostic imaging PACS system upgrade at San Mateo Medical Center, special education contracted services at Birdville Independent School District, and a temporary health professional staffing qualification pool at the County of Santa Clara Health System—do not reflect genetic or cytogenetic testing services for autosomal rearrangement diagnosis. The San Mateo PACS opportunity involves radiology, cardiology, and dental imaging system implementation rather than genetic diagnostic work; the Birdville ISD solicitation covers educational and therapeutic services (audiologists, speech-language therapists, occupational therapists, and similar specialists) for K–12 populations; and the Santa Clara Health System posting seeks ancillary clinical staffing (audiology, respiratory care, surgical support) without reference to genetic testing or laboratory diagnostics. The code's nominal scope does not match the work actually being solicited under this identifier in state and local procurement right now.

No recent state and local opportunities specifically solicit genetic diagnosis, cytogenetic analysis, or laboratory testing services aligned with the code's stated purpose. The mismatch between the code definition and the opportunities tagged to it suggests either a data-entry error in the source system or a systematic misclassification. For firms pursuing contracts in genetic diagnostics, prenatal screening, or cytogenetic services at public hospitals, health systems, or state laboratory facilities, this code does not currently surface relevant demand signals. Tracking this code for future activity is warranted only if issuers begin correctly tagging genetic-testing solicitations to it; as presently indexed, it offers limited intelligence value for business development in that market.